Reducing sedentary behavior in prostate cancer survivors
A Distance-based, Randomized Controlled Trial for Reducing Sedentary Behaviour Among Prostate Cancer Survivors
This study is testing if a special program with support and a FitBit can help prostate cancer survivors move more and sit less over 12 weeks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | University of Toronto Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT05214937 on ClinicalTrials.gov |
What this trial studies
This randomized controlled trial aims to evaluate a 12-week behavioral intervention designed to reduce sedentary behavior among prostate cancer survivors. Participants in the intervention group will receive a FitBit and six behavioral support sessions with a movement specialist, guided by the Multi-Process Action Control (M-PAC) framework. The control group will only receive a FitBit and access to public health resources. The study will assess the effectiveness of the intervention on sedentary behavior and physical activity levels immediately after the intervention and six months later.
Who should consider this trial
Good fit: Ideal candidates for this study are prostate cancer survivors aged 18 and older who are not currently undergoing radiation or chemotherapy and report high levels of sedentary behavior.
Not a fit: Patients who are physically active or have medical conditions that prohibit walking may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of life and health outcomes for prostate cancer survivors by reducing sedentary behavior.
How similar studies have performed: While there is growing evidence supporting the reduction of sedentary behavior for health benefits in cancer survivors, this specific approach using the M-PAC framework is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>= 18 years of age * Diagnosed with localized or asymptomatic metastatic primary prostate cancer * Not currently undergoing radiation or chemotherapy * Proficient in English * Not physically active (self report \<150 minutes of moderate-to-vigorous physical activity per week) * Self-report \>8 hours of daily sedentary behaviour * In the contemplation or preparation stage for motivational readiness to change as determined by the Stages of Change Questionnaire * Access to a smartphone, tablet, or computer * No cardiac contraindications (e.g., unstable angina, arrhythmia, heart failure, aortic stenosis) * Medical clearance from a primary health care provider (if necessary) * Currently residing in Canada Exclusion Criteria: * Not planning to live in Canada for the next 12 months * A medical condition that prohibits walking (e.g., severe knee or hip arthritis) * Presence of other primary or recurrent invasive cancer (i.e., other than non-melanoma skin cancer) * Have had a prior fall within the last 12-months * Use a gait aid device
Where this trial is running
Toronto, Ontario
- University of Toronto — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Linda Trinh, PhD — University of Toronto
- Study coordinator: Linda Trinh, PhD
- Email: linda.trinh@utoronto.ca
- Phone: 416-946-3624
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.